2022 Controlled Substances and Beyond: The Pain Puzzle, A Comprehensive Review

Friday, June 3, 2022, 8:00 AM - 4:30 PM, Online, Stanford, CA

The Center for Advanced Practice is proud to offer an advanced practice program geared toward prescribing providers that focuses on the principles of pharmacology across the lifespan in relation to Schedule II-V controlled substances. The course explores assessment, treatment, management, evaluation, and standardized procedures and protocols of controlled substances, with an emphasis on Schedule II.  Additionally, the course will review the legal and prescribing aspects associated with pain management as well as misuse, abuse, drug diversion, controlled substances in the pediatric population, and ethical considerations. This is an all-day program with a spectacular advanced practice faculty.

This course meets the California Code of Regulations Sections 1399.610 and 1399.612 requirements.

1. Describe how implicit bias may impact pain management and discuss ethical strategies that the provider can use to minimize their effect in the clinical setting.
2. Identify and examine the diagnosis and management of common disorders, including but not limited to acute pain, chronic pain, ADHD, addiction/substance use disorders; that may require CS II-V management as well as the provision of appropriate patient/provider education regarding controlled substances (CS II-V) across the lifespan, in a patient-specific/specialty protocol or practice by the Business and Profession Code, Section 2836.1.
3. Discuss the spectrum of treatment options available for pain management, including comparing efficacy and safety profiles that influence the selection, usage, clinical rationale for use, and conversion of pharmacological agents.
4. Analyze state laws and federal regulations on furnishing, dispensing, and administering controlled substances Schedule II-V for nurse practitioners and physician assistants.

• Student Price: $99.00 (Please email your student ID to [email protected]  to receive a coupon code. The PA board might not accept a certificate of completion without a PA license number. )
• Early-bird Fee: $99.00 (Ends 4/15/2022)
• Regular Fee: $119.00 (Begins 4/16/2022)

There is no refund for cancellation or no show. 

ANCC - American Nurses Credentialing Center contact hour(s) (7.25 hours), General Attendance (7.25 hours), AAPA- American Academy of Physician Assistants Category 1 CME credit(s) (7.25 hours), ANCC Pharma- American Nurse Credentialing Center Pharma contact hour(s) (7.25 hours), CA BRN - California Board of Registered Nurses contact hour(s) (7.25 hours)

1. Stanford Health Care is a provider approved by the California Board of Registered Nursing (BRN). Provider Number CEP12165.
2. Stanford Health Care Center for Education and Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Neither SHC nor ANCC endorses any commercial products.
3. This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 7.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 6/3/2022 to 9/2/2022. AAPA reference number: CME-205744.

©2022 by Stanford Health Care, Division of Patient Care Services.
All rights reserved. No audio or video taping allowed. We reserve the right to make program changes. All students must be registered, attend the entire course, and submit an evaluation after course completion to earn credit hours.

Mitigation of Relevant Financial Relationships

Stanford Health Care (SHC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, June 3, 2022